The North America Demineralized Bone Matrix Market would witness market growth of 5.0% CAGR during the forecast period (2023-2030).
The US market dominated the North America Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $538 million by 2030. The Canada market is experiencing a CAGR of 7.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.4% during (2023 - 2030).
The market represents a dynamic and rapidly evolving segment within the orthopaedic and dental industries. Demineralized bone matrix (DBM), derived from allograft bone tissue, undergoes a demineralization process to remove inorganic minerals while preserving their natural osteoinductive and osteoconductive properties. The versatility of DBM is reflected in its diverse range of applications across orthopaedic and dental specialties.
DBM is commonly used in spinal fusion, fracture repair, joint reconstruction, and bone defect augmentation procedures. Its osteoinductive properties stimulate the recruitment and differentiation of osteogenic cells, promoting new bone formation and enhancing the healing process. Additionally, DBM is a valuable adjunct in orthopaedic trauma cases, facilitating the repair of complex fractures and non-unions.
High vehicle injuries often result in traumatic fractures and bone defects requiring surgical intervention. Orthopedic surgeons may utilize DBM as a bone grafting material to promote bone regeneration and facilitate the healing of complex fractures. According to the Government of Canada, in 2021, there were 1,768 motor vehicle fatalities, representing a 1.3% increase from the 1,746 fatalities reported in 2020. Hence, increasing traffic injuries and rising trauma cases in the region propel the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Demineralized Bone Matrix Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $538 million by 2030. The Canada market is experiencing a CAGR of 7.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.4% during (2023 - 2030).
The market represents a dynamic and rapidly evolving segment within the orthopaedic and dental industries. Demineralized bone matrix (DBM), derived from allograft bone tissue, undergoes a demineralization process to remove inorganic minerals while preserving their natural osteoinductive and osteoconductive properties. The versatility of DBM is reflected in its diverse range of applications across orthopaedic and dental specialties.
DBM is commonly used in spinal fusion, fracture repair, joint reconstruction, and bone defect augmentation procedures. Its osteoinductive properties stimulate the recruitment and differentiation of osteogenic cells, promoting new bone formation and enhancing the healing process. Additionally, DBM is a valuable adjunct in orthopaedic trauma cases, facilitating the repair of complex fractures and non-unions.
High vehicle injuries often result in traumatic fractures and bone defects requiring surgical intervention. Orthopedic surgeons may utilize DBM as a bone grafting material to promote bone regeneration and facilitate the healing of complex fractures. According to the Government of Canada, in 2021, there were 1,768 motor vehicle fatalities, representing a 1.3% increase from the 1,746 fatalities reported in 2020. Hence, increasing traffic injuries and rising trauma cases in the region propel the market’s growth.
Based on End-use, the market is segmented into Outpatient Facilities, and Hospitals. Based on Product Type, the market is segmented into Putty, Fiber, Sponge, Paste, Gel, and Others. Based on Application, the market is segmented into Spinal Fusion, Dental, Joint Reconstruction, Hand, Foot, & Ankle, Long Bone, and Craniomaxillofacial. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- Putty
- Fiber
- Sponge
- Paste
- Gel
- Others
- Government
- Energy
- Defense
- Agriculture & Forestry
- Media & Entertainment
- Civil Engineering & Archaeology
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Demineralized Bone Matrix Market by End-use
Chapter 5. North America Demineralized Bone Matrix Market by Product Type
Chapter 6. North America Demineralized Bone Matrix Market by Application
Chapter 7. North America Demineralized Bone Matrix Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Zimmer Biomet Holdings, Inc.
- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Arthrex, Inc.
- Globus Medical, Inc.
- Berkeley Advanced Biomaterials
- Xtant Medical Holdings, Inc.
- Orthofix Medical Inc.
- Institut Straumann AG
Methodology
LOADING...
